Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 2

2(25.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(4)

Phase 2(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05353829Phase 4Active Not Recruiting

Methotrexate in Patients with Early Rheumatoid Arthritis

Role: collaborator

NCT06166199Not ApplicableRecruiting

Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus

Role: collaborator

NCT05600517Not ApplicableUnknown

Evaluation of Caries Prevention Based on Genetic Etiology and Risk.

Role: collaborator

NCT02378519Not ApplicableUnknown

Interactive Web-based Program and CBT-coaching With Physiotherapy for Patients With Chronic Musculoskeletal Pain

Role: collaborator

NCT00412659Phase 2Completed

Mid-line Excision Versus Karydakis Operation for Pilonidal Sinus

Role: collaborator

NCT01061632Phase 2Completed

High(Deadlift) Versus Low Intensity Motor Control Exercises on Low Back Pain

Role: collaborator

NCT01478672Not ApplicableCompleted

Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten

Role: collaborator

NCT00486941Phase 3Completed

Lifestyle Intervention in Primary Health Care - the Björknäs Study

Role: collaborator

All 8 trials loaded